Arcturus therapeutics to present at the 42nd annual j.p. morgan healthcare conference

San diego--(business wire)---- $arct #clinicaltrial--arcturus therapeutics holdings inc. (the “company”, “arcturus”, nasdaq: arct), a global late-stage clinical messenger rna medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that joseph payne, president & chief executive officer, will present at the 42nd annual j.p. morgan healthcare conference in san francisco, on tuesday, january 9, 2024, at 3:00 p.
ARCT Ratings Summary
ARCT Quant Ranking